1100 New York Ave. NW, Suite 340, Washington, D.C. 20005 Call 1-800-THE-FIRM 24 hours a day
  • About Us
  • Q & A
  • Contact Us

Invokana Lawsuit

LOCAL PHONE: (202) 682-5800
TOLL FREE: 1-800-THE-FIRM (843-3476)
  • Home
  • About Us
    • Invokana lawsuit TV commercial
  • Invokana Information
    • How can an Invokana lawsuit help me?
    • FDA on Invokana
    • SGLT2 Inhibitor Injuries
    • Invokana urosepsis infection lawsuit
    • Invokana pyelonephritis, kidney infection lawsuit
    • Invokana heart attack
    • Invokana kidney injuries
    • Invokana bone fractures
    • Invokana and ketoacidosis
    • FDA Orders Heart Attack Study of Invokana
    • Safety group questions Invokana
  • Invokana Attorneys
    • Invokana lawsuit
    • Invokamet lawsuit
    • Farxiga lawsuit
    • Jardiance lawsuit
    • Glyxambi lawsuit
    • Xigduo XR lawsuit
  • Questions & Answers
  • Blog
  • Contact Us
  • Home
  • About Us
    • Invokana lawsuit TV commercial
  • Invokana Information
    • How can an Invokana lawsuit help me?
    • FDA on Invokana
    • SGLT2 Inhibitor Injuries
    • Invokana urosepsis infection lawsuit
    • Invokana pyelonephritis, kidney infection lawsuit
    • Invokana heart attack
    • Invokana kidney injuries
    • Invokana bone fractures
    • Invokana and ketoacidosis
    • FDA Orders Heart Attack Study of Invokana
    • Safety group questions Invokana
  • Invokana Attorneys
    • Invokana lawsuit
    • Invokamet lawsuit
    • Farxiga lawsuit
    • Jardiance lawsuit
    • Glyxambi lawsuit
    • Xigduo XR lawsuit
  • Questions & Answers
  • Blog
  • Contact Us

Blog

You are here: Home → Blog

Latest FDA Invokana alert warns patients of foot and leg amputations

Posted By David Haynes in Uncategorized May 18, 2016 0 comment
Invokana study shows Invokana patients twice as likely for risk of amputation The Food and Drug Administration recently published a Drug Safety Commu...
Continue Read
fda warns invokana may cause serious kidney infections

New FDA warnings for Invokana Invokana may cause diabetic ketoacidosis, serious infections

Posted By David Haynes in Uncategorized December 9, 2015 0 comment
The Food and Drug Administration recently issued a Drug Safety Communication adding warnings to the labels of sodium glucose-cotransporter (SGLT2) inh...
Continue Read

Type 1 diabetes patients taking Invokana developed ketoacidosis Despite lowering HbA1c levels, Invokana may increase risk of serious side effects

Posted By David Haynes in Uncategorized November 17, 2015 0 comment
Invokana studies conducted at the University of San Diego this summer appear to show a link between taking the drug to treat type 1 diabetes and devel...
Continue Read
09 Invokana-Injury-Lawyer

Invokana Q3 sales almost double from 2014

Posted By David Haynes in Diabetic Ketoacidosis, Invokana, ketoacidosis October 20, 2015 0 comment
Johnson & Johnson report $340 million in 2015 Q3 sales Third quarter Invokana sales in 2015 skyrocketed 95.4% over the same quarter in 2014, acco...
Continue Read

Invokana maker giving millions to doctors to promote the diabetes drug

Posted By David Haynes in Uncategorized October 6, 2015 0 comment
Janssen Pharmaceuticals paying doctors for speaking fees, consulting, and travel to promote Invokana According to data provided by non-profit investi...
Continue Read

Invokana class action lawsuit filed in Canada

Posted By David Haynes in Invokana September 29, 2015 0 comment
Claim alleges negligence on the part of Janssen, Johnson & Johnson This month, a class action lawsuit seeking an excess of $1 billion in dama...
Continue Read
14 Invokana

FDA strengthens warning label for Invokana, linking drug to increased bone fractures Type 2 diabetes SGLT2 medication linked to decreased bone mineral density

Posted By David Haynes in Uncategorized September 11, 2015 0 comment
The Food and Drug Administration (FDA) recently bolstered warning labels for Invokana (canagliflozin) and Invokamet.  The new prescription warning lab...
Continue Read

Australian health officials issue Invokana safety advisory

Posted By David Haynes in Uncategorized August 25, 2015 0 comment
Therapeutic Goods Administration warns of ketoacidosis risk This month, the Australian Department of Health’s Therapeutic Goods Administration (TGA) ...
Continue Read
AACE-logo-large

Leading medical association on diabetes care announces SGLT2 safety conference

Posted By David Haynes in Uncategorized August 19, 2015 0 comment
American Association of Clinical Endocrinologists (AACE) to discuss links between drugs like Invokana and ketoacidosis In October 2015, the American ...
Continue Read
diabetes

Where do reports on possible Invokana side effects come from?

Posted By David Haynes in Uncategorized August 10, 2015 0 comment
FDA, ISMP warn Invokana users about possible risks of developing serious medical conditions Invokana is part of a new class of type 2 diabetes medica...
Continue Read
1 2

Recent Posts

Latest FDA Invokana alert warns patients of foot and leg amputations

May 18, 2016
fda warns invokana may cause serious kidney infections

New FDA warnings for Invokana

December 9, 2015

Type 1 diabetes patients taking Invokana developed ketoacidosis

November 17, 2015
09 Invokana-Injury-Lawyer

Invokana Q3 sales almost double from 2014

October 20, 2015

Invokana maker giving millions to doctors to promote the diabetes drug

October 6, 2015

Categories

  • Diabetic Ketoacidosis
  • Invokana
  • ketoacidosis
  • Uncategorized

About Us

The attorneys of The Cochran Firm, D.C. are providing free consultations for people who suffered health complications or side effects caused by Invokana and other type 2 diabetes medications.

INVOKANA LAWYERS

Washington, D.C.

1100 New York Ave. NW, Suite 340, Washington, D.C. 20005

Tel: 202-682-5800
Monday - Friday: 9:00 AM - 5:00 PM

Tel: 1-800-THE-FIRM (843-3476)
24 hours a day

Baltimore, MD

6 E. Biddle Street, Suite 100, Baltimore, MD 21202

Get the Latest Invokana Lawsuit News

Copyright © 2015 The Cochran Firm DC Personal Injury Lawyers. Read our Privacy Policy
Goto Top